VABYSMO
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for VABYSMO, covering 2022-01-28 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Vabysmo (Faricimab) — Roche Registration GmbH
20 regulatory and trial events tracked for VABYSMO, covering 2022-01-28 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Vabysmo (Faricimab) — Roche Registration GmbH